Intraventricular Infusion of Vascular Endothelial Growth Factor Promotes Cerebral Angiogenesis with Minimal Brain Edema
- 1 March 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 50 (3), 589-598
- https://doi.org/10.1097/00006123-200203000-00030
Abstract
OBJECTIVE: Therapeutic cerebral angiogenesis, i.e., using angiogenic factors to enhance collateral vessel formation within the central nervous system, is a potential method for cerebral revascularization. Vascular endothelial growth factor (VEGF) is a potent endothelial cell mitogen that also increases capillary permeability, particularly in ischemic tissue. The purpose of this study was to assess the angiogenic and capillary permeability effects of chronic intraventricular infusion of exogenous VEGF in nonischemic brain tissue, because many patients with impaired cerebrovascular reserve do not exhibit chronic cerebral ischemia.METHODS: Recombinant human VEGF165 was infused into the right lateral ventricle of rats at a rate of 1 μl/h for 7 days, at concentrations of 1 to 25 μg/ml, with osmotic minipumps. Control animals received vehicle only. Vessels were identified in laminin immunohistochemical analyses. Capillary permeability and brain edema were assessed with Evans blue extravasation, [3H]inulin permeability, and brain water content measurements.RESULTS: Vessel density was dose-dependently increased by VEGF165 infusions, with significant increases occurring in animals treated with 5 or 25 μg/ml, compared with control animals (P < 0.01). Significant enlargement of the lateral ventricles was observed for the highest-dose group but not for animals treated with other doses. Capillary permeability was assessed in animals treated with a dose of 5 μg/ml. An increase in capillary permeability in the diencephalon was identified with Evans blue extravasation and [3H]inulin permeability assessments; however, the brain water content was not significantly increased.CONCLUSION: Chronic intraventricular infusions of VEGF165 increased vascular density in a dose-dependent manner. There seems to be a therapeutic window, because infusion of VEGF165 at a concentration of 5 μg/ml resulted in a significant increase in vessel density with minimal associated brain edema and no ventriculomegaly.Keywords
This publication has 50 references indexed in Scilit:
- Constitutive Expression of phVEGF 165 After Intramuscular Gene Transfer Promotes Collateral Vessel Development in Patients With Critical Limb IschemiaCirculation, 1998
- Increased blood–brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factorJournal of Neurocytology, 1998
- Heterodimers of Placenta Growth Factor/Vascular Endothelial Growth FactorJournal of Biological Chemistry, 1996
- Synergistic Effect of Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor on Angiogenesis In VivoCirculation, 1995
- Differential Expression of Vascular Endothelial Growth Factor (Vascular Permeabilty Factor) Forms in Rat TissuesGrowth Factors, 1995
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994
- Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic RetinopathyAmerican Journal of Ophthalmology, 1994
- Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs.Circulation, 1994
- Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing.The Journal of Experimental Medicine, 1992
- Mechanisms of AngiogenesisAnnual Review of Physiology, 1987